A New Score to Identify High-Risk, Severe COVID-19 Patients
Researchers identified a prognostic BAS2IC score to assist physicians in identifying patients at high-risk of developing early severe COVID-19.
All articles by Bradley van Paridon
COVID-19: Assessing Antibody Responses and Clinical Outcomes in Severe Disease
Levels of immunoglobulin G antibodies against nucleocapsid, the spike protein, and the receptor binding domain were related to viral clearance.
Exploring Potential Biomarkers for Severe COVID-19 and Moderate to Severe ARDS
Neutrophil-to-lymphocyte ratio may be a valuable biomarker to help clinicians recognize severe COVID-19 infection with moderate to severe ARDS.
COVID-19: Despite Strict Hygiene, Asymptomatic Transmission Rate High at Skilled Nursing Facility
At a skilled nursing facility in Massachusetts, researchers found an 85% prevalence of the SARS-CoV-2 virus among asymptomatic facility residents.
COVID-19: Distance, Population, Weather Associated With Decreased SARS-CoV-2 Reproduction Number
Study results may provide guidance for healthcare policy and pandemic management at a selective, local level.
Clinical Practice Guideline: Treatment of Nontuberculous Mycobacterial Pulmonary Disease
New clinical practice guidelines for the treatment of nontuberculous mycobacterial pulmonary disease were published by leading respiratory medicine and infectious disease societies.
Elevated Inflammatory Markers in HIV May Lead to Worse Outcomes in COVID-19
Despite treatment with antiretroviral therapies, people with HIV may be more likely to experience severe manifestations of COVID-19.
Clinical Outcomes Associated With Ibuprofen Use During COVID-19
A team of investigators assessed clinical outcomes among patients with COVID-19 receiving ibuprofen for fever reduction.
Reactogenicity of Enhanced Influenza Vaccines in Older Adults
A team of investigators report on the findings from a randomized controlled trial of 3 enhanced influenza vaccines and a standard-dose vaccine in older adults.
Characteristics and Outcomes of Heart Transplant Recipients With COVID-19
As heart transplant recipients may be at increased risk for infection with COVID-19, investigators sought to identify characteristics, treatment, and outcomes of this patient population.
-
Loading...
-
Loading...
Next post in Lung Infection
